Semaglutide May Be Linked to Condition That Causes Blindness
Med Page Today
JULY 3, 2024
(MedPage Today) -- Use of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy) may be linked with an increased risk of the second most common form of optic neuropathy, a retrospective study suggested. Over a mean follow-up of nearly 3 years.
Let's personalize your content